Global Cell Therapy Market Trends, Strategies, And Opportunities In The Cell Therapy Market 2021-2030

Cell Therapy Market Report 2021: COVID-19 Growth And Change

Cell Therapy Global Market Report 2021: COVID-19 Growth And Change

Cell Therapy Global Market Report 2021: COVID-19 Growth And Change

LONDON, GREATER LONDON, UK, September 23, 2021 / — According to the new market research report ‘Cell Therapy Global Market Report 2021: COVID-19 Growth And Change’ published by The Business Research Company, the cell therapy market is expected to grow from $7.2 billion in 2020 to $7.82 billion in 2021 at a compound annual growth rate (CAGR) of 8.6%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $12.06 billion in 2025 at a CAGR of 11%. The rising prevalence of chronic diseases contributed to the growth of the cell therapy market.

Request For A Sample For The Global Cell Therapy Market Report:

The cell therapy market consists of sales of cell therapy and related services. Cell therapy (CT) helps repair or replace damaged tissues and cells. A variety of cells are used for the treatment of diseases includes skeletal muscle stem cells, hematopoietic (blood-forming) stem cells (HSC), lymphocytes, mesenchymal stem cells, pancreatic islet cells, and dendritic cells.

Trends In The Global Cell Therapy Market
Key players in the market are strategically partnering and collaborating to expand the product portfolio and geographical presence of the company. For instance, in April 2018, Eli Lilly, an American pharmaceutical company entered into a collaboration agreement with Sigilon Therapeutics, a biopharmaceutical company that focused on the discovery and development of living therapeutics to develop cell therapies for type 1 diabetes treatment by using the Afibromer technology platform. Similarly, in September 2018, CRISPR Therapeutics, a biotechnological company that develops transformative medicine using a gene-editing platform for serious diseases, and ViaCyte, a California-based regenerative medicine company, collaborated on the discovery, development, and commercialization of allogeneic stem cell therapy for diabetes treatment.

Global Cell Therapy Market Segments:
The global cell therapy market is further segmented based on technique, therapy type, application and geography.
By Technique: Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy
By Therapy Type: Allogeneic Therapies, Autologous Therapies
By Application: Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Others
By Geography: The global cell therapy market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Read More On The Report For The Global Cell Therapy Market At:

Cell Therapy Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides cell therapy market overviews, analyzes and forecasts market size and growth for the global cell therapy market, cell therapy market share, cell therapy market players, cell therapy market segments and geographies, cell therapy market’s leading competitors’ revenues, profiles and market shares. The cell therapy market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Read Cell Therapy Global Market Report 2021 from The Business Research Company for information on the following:

Data Segmentations: Market Size, Global, By Region And By Country; Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries

Cell Therapy Market Organizations Covered: Fibrocell Science Inc., JCR Pharmaceuticals Co. Ltd., PHARMICELL Co. Ltd., Osiris Therapeutics Inc., MEDIPOST, Vericel Corporation, Anterogen Co. Ltd., Kolon TissueGene Inc., Stemedica Cell Technologies Inc., AlloCure, Arteriocyte Medical Systems, Athersys Inc., Baxter Healthcare Corporation, Bone Therapeutics, Celgene Corporation, Cell Medica, Cellerant Therapeutics, Forticell Bioscience, Mesoblast Ltd, AlloSource, Holostem Terapie Avanzate S.r.l, Pharmicell Co. Ltd, TiGenix (Takeda Pharmaceuticals), Stempeutics Research Pvt. Ltd., Nipro Corp, Tego Science, Corestem Inc., Forticell Bioscience, Cellerant Therapeutics, Cells for Cells.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Interested to know more about The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Get a quick glimpse of our services here:

Here is a list of reports from The Business Research Company similar to the Cell Therapy Global Market Report 2021:

Cell Therapy Technologies Global Market Report 2021 – By Product (Consumables, Equipment, Systems & Software), By Cell Type (T-Cells, Stem Cells), By Process (Cell Processing, Cell Preservation, Distribution And Handling, Process Monitoring And Quality Control), By End-User (Life Science Companies, Research Institutes), COVID-19 Growth And Change

Cell And Gene Therapy Market – By Product (Cell Therapy, Gene Therapy), By Application (Oncology, Neurological Disorders, Others) And By Region, Opportunities And Strategies – Global Forecast To 2030

Stem Cell Therapy Global Market Report 2021 – By Type (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), By Cell Source (Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells), By Application (Musculoskeletal Disorders, Wounds And Injuries, Cancer, Autoimmune Disorders), By End-User (Hospitals, Clinics), COVID-19 Growth And Change

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

The Business Research Company
Follow us on LinkedIn:
Follow us on Twitter:
Check out our Blog:

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
Visit us on social media:

Leave a Reply

Your email address will not be published.